STUDIES ON ENHANCEMENT OF ORAL BIOAVAILABITY OF PACLITAXEL BY NANO SUSPENSION TECHNOLOGY

Main Article Content

Abbineni Anusha
Dr.A.Lakshman rao
Dr.M.V.Basaveswara rao

Keywords

paclitaxel nano suspension, SLS, Edragit S 100, PVP K30, poloxamer188.

Abstract

The objective of the present work was to formulate and evaluate drug  release paclitaxel nano suspension for treating breast, ovarian   and colon cancer effectively. Different formulations were prepared by using Solvent Evaporation technique using synthetic polymer like SLS, Edragit S 100, PVP K30, poloxamer188. The formulations were evaluated for percentage yield, entrapment efficiency, particle size analysis, and In-vitro drug release. The optimized formulation of the Nano suspensions containing polymer and drug was found to be compatible from FTIR studies. The In-vitro release of drug from the formulations were studied in pH 6.8 phosphate buffer solution, and it was found that the prepared nano suspension (F 3) were able to the drug release of the drug 45 mins of about 98.40%. and following the kinetics of first order release.

Abstract 16 | pdf Downloads 4

References

1. Nagare SK, A review on Nanosuspension: An innovative acceptable approach in novel delivery system, UJP, 2012; 1(1):19-31.
2. Debjit B, Nanosuspension -A Novel Approaches in Drug Delivery System. The JPI, 2012; 1(12):50-63.
3. Kamble VA, Nanosuspension A Novel Drug Delivery System, IJPBS, 2010; 1:352- 360.
4. Yadav GV, Singh SR. Nanosuspension: A Promising Drug Delivery System. An International Research Journal- Pharmacophore 2012; 3 (5): 217-243.
5. Patravale VB, Abhijit AD and Kulkarni RM. Nanosuspensions: a promising drug delivery strategy. J.Pharm.Pharcol, 2004; 5(6): 827-840
6. Keck MC, Muller RH. Drug nanocrystals of poorly soluble drugs produced by high- pressure homogenisation. Eur. J. Pharm.Biopharm,2006; 6(2):3–16.
7. Kavitha V.B, Neethu C.S, Dinesh KB, Krishna KK, John A. Nanosuspension Formulation: An Improved Drug Delivery System. Nanoscience and Nanotechnology: An International Journal, 2014; 4(1): 1-5.
8. Vezin W.R., Khan K.A. and Pang H.M., Journal of Pharmacy and Pharmacology 1983;35: 555-558
9. Aulton ME: Pharmaceutics; The Science of Dosage Form Design. Churchill Livingstone, London, Second Edition 2002.
10. Aulton ME: Pharmaceutics; The Science of Dosage Form Design. Churchill Livingstone, London, Second Edition 2002.
11. Oth M, Franze M et al. The bilayer floating capsule: a stomach directed drug delivery system for misoprostol. Pharm Res, 1992, 9(8), 298-302.
12. Gergogiannins YS et al. Floating and swelling characteristic of various excipients used in controlled release technology. Drug Dev Ind Pharm, 1993, 19(6), 1061- 1081.
13. Costa P., Sousa L. J. M., Modelling and comparison of dissolution profiles, EUFEPS 2001; 13:2: 123–133.
14. Vijay Agarwal, and Meenakshi Bajpai3,Preparation and Optimization of Esomeprazole Nanosuspension using Evaporative Precipitation–Ultrasonication, TROP J PHARM RES April 2014; 13 (4): 497-503.
15. Dash S, Murthy PN, Nath L and Chowdhury P: Kinetic modeling on drug release from CRDDS. Acta Poloniae Pharmaceutica - Drug Research 2010; 67: 217-223.
16. Velmula M, Pavuluri P, Rajashekar S, Dr. Rao VUM. Nanosuspension Technology for Poorly Soluble Drugs - A Review. WJPPS 2015; 4(7):01612-1625.
17. Mohanty S, Role of Nanoparticles in Drug Delivery System, Int. j. pharm. biomed., 2010; 1 (2): 41-66.
18. Ch.P .A Review on Nanosuspensions In Drug Delivery, IJPBS,2011; 2: 549-558.
19. Nagare SK, A review on Nanosuspension: An innovative acceptable approach in novel delivery system, UJP, 2012; 1(1):19-31.
20. Debjit B, Nanosuspension -A Novel Approaches in Drug Delivery System. The JPI, 2012; 1(12):50-63.
21. Kamble VA, Nanosuspension A Novel Drug Delivery System, IJPBS, 2010; 1:352- 360.